Yoshihiro Niitsu

Yoshihiro Ogawa2
Masahiro Asakawa2
Atsuko Miyake2
Tetsuo Sekine2
Mitsunobu Kawamura2
2Yoshihiro Ogawa
2Masahiro Asakawa
2Atsuko Miyake
2Tetsuo Sekine
2Mitsunobu Kawamura
Learn More
AIM To investigate the efficacy and safety of a dipeptidyl peptidase-4 inhibitor, sitagliptin, for treating diabetes mellitus complicated by chronic liver injury. METHODS Sitagliptin was administered for 13.7 ± 10.1 months to 122 patients with DM complicated by chronic liver injury (including 19 patients with liver cirrhosis), and changes in hemoglobin(More)
A 73-year-old woman admitted to our hospital because of headache, poor appetite, malaise, weight loss, and vomiting was found to have central adrenal insufficiency and thyrotoxicosis due to silent thyroiditis. Polyuria developed after replacement with glucocorticoid (masked diabetes insipidus), which was controlled with nasal administration of desmopressin.(More)
  • 1